Key Points CorMedix will acquire substantially all of Heron’s assets, including four commercial medicines, for cash, shares and potential future payments. Upfront consideration was valued…
November 09, 2026
Key Points Abeona acquired Ellodi Pharmaceuticals’ APT-1011, renamed ABO-801, for $20 million in common stock and potential future payments. The once-daily dissolving tablet is being…
Key Points Merck KGaA, Darmstadt, Germany, agreed to acquire Silence Therapeutics for $20 per American Depositary Share in cash. The offer represents a 130% premium…
Key Points David Ellison will serve as chairman and CEO of the combined company, while former Mattel CEO Ynon Kreiz will become co-CEO and oversee…
Key Points Curaleaf increased its proposed acquisition offer for Aurora Cannabis by 25% to implied consideration of $5.00 per Aurora share. The enhanced offer consists…
Key Points BioXcel filed Chapter 11 cases in Delaware to conduct a court-supervised sale of substantially all company assets. Teva Pharmaceuticals International GmbH signed an…
Key Points The companies expect the transaction to close in Q4 2026, subject to shareholder, regulatory, court, Nasdaq, and other approvals. Fibrx will be led…
July 21, 2026
Cardinal Health Buys Diabetes and Home Care Assets in a $360 Million Push Into At‑Home Chronic Care
Cardinal Health (NYSE: CAH) will acquire AdaptHealth’s diabetes health business and multi‑specialty supply company Strive Medical in two separate transactions, totaling about $360 million. AdaptHealth…
July 20, 2026
Magnolia’s Big South Texas Bet on WildFire Energy
Magnolia Oil & Gas Corporation (NYSE: MGY) has agreed to acquire privately held WildFire Energy in a transaction valued at about $4.06 billion, including assumed…
Passage Bio (NASDAQ: PASG) is handing the keys to Remix Therapeutics in an all‑stock reverse merger that will take Remix public, rebrand the combined company…
Kontoor Brands (NYSE: KTB) is selling its Lee business to Authentic Brands Group in a deal worth up to $1 billion, pivoting its focus toward Wrangler…
Artivion, Inc. (NYSE: AORT) is paying about $135 million upfront to acquire Endospan Ltd., locking in the FDA‑approved NEXUS Aortic Arch System and significantly strengthening its aortic…